Incidence and intensity of PET positivity according to disease characteristics in studied population
| . | PET . | . | . | . | |
|---|---|---|---|---|---|
| . | Positive (n = 123), n (%) . | Negative (n = 50), n (%) . | P . | SUV (mean ± SD) . | P . |
| Origin site | .000 | .032 | |||
| Stomach | 21 (50.0) | 21 (50.0) | 5.8 ± 1.9 | ||
| Lung | 34 (100.0) | 0 | 5.9 ± 4.4 | ||
| Skin | 5 (22.7) | 17 (77.3) | 3.7 ± 3.9 | ||
| Orbit | 15 (71.4) | 6 (28.6) | 6.3 ± 4.1 | ||
| Rare site | |||||
| Head and neck | 11 (100.0) | 0 | 7.9 ± 3.9 | ||
| Soft tissue | 10 (100) | 0 | 7.3 ± 3.9 | ||
| Parotid gland | 5 (71.4) | 2 (28.6) | 7.7 ± 3.7 | ||
| CNS | 3 (60.0) | 2 (40.0) | 5.2 ± 2.2 | ||
| Thyroid | 4 (100.0) | 0 | 14.8 ± 6.2 | ||
| Bowel | 3 (100.0) | 0 | 6.9 ± 3.2 | ||
| Breast | 1 (33.3) | 2 (66.7) | 2.6 | ||
| Others | 11 (100.0) | 0 | 8.9 ± 7.5 | ||
| Age, y | .055 | .295 | |||
| <70 | 83 (33.1) | 41 (66.9) | 4.6 ± 4.9 | ||
| ≥70 | 40 (18.4) | 9 (81.6) | 5.4 ± 5.0 | ||
| ECOG PS | .323 | .140 | |||
| 0-1 | 118 (70.2) | 50 (29.8) | 6.6 ± 4.5 | ||
| ≥2 | 5 (100) | 0 | 9.7 ± 4.7 | ||
| Stage | .161 | .058 | |||
| I-II | 80 (67.8) | 38 (32.2) | 4.3 ± 4.6 | ||
| III-IV | 43 (78.2) | 12 (21.8) | 5.8 ± 5.3 | ||
| LDH | .317 | .390 | |||
| Normal | 105 (69.5) | 46 (30.5) | 6.7 ± 4.4 | ||
| Elevated | 18 (81.8) | 4 (18.2) | 7.6 ± 5.1 | ||
| IPI | .000 | .578 | |||
| 0 | 28 (50.9) | 27 (49.1) | 6.1 ± 4.6 | ||
| 1 | 41 (74.5) | 14 (25.5) | 6.8 ± 4.5 | ||
| 2 | 27 (81.8) | 6 (18.2) | 6.5 ± 5.2 | ||
| ≥3 | 27 (90.0) | 3 (10.0) | 7.7 ± 3.8 | ||
| MALT-IPI | .035 | .034 | |||
| 0 | 47 (61.8) | 29 (38.2) | 3.8 ± 4.6 | ||
| 1 | 52 (75.4) | 17 (24.6) | 5.3 ± 4.6 | ||
| ≥2 | 24 (85.7) | 4 (14.3) | 6.4 ± 5.9 | ||
| . | PET . | . | . | . | |
|---|---|---|---|---|---|
| . | Positive (n = 123), n (%) . | Negative (n = 50), n (%) . | P . | SUV (mean ± SD) . | P . |
| Origin site | .000 | .032 | |||
| Stomach | 21 (50.0) | 21 (50.0) | 5.8 ± 1.9 | ||
| Lung | 34 (100.0) | 0 | 5.9 ± 4.4 | ||
| Skin | 5 (22.7) | 17 (77.3) | 3.7 ± 3.9 | ||
| Orbit | 15 (71.4) | 6 (28.6) | 6.3 ± 4.1 | ||
| Rare site | |||||
| Head and neck | 11 (100.0) | 0 | 7.9 ± 3.9 | ||
| Soft tissue | 10 (100) | 0 | 7.3 ± 3.9 | ||
| Parotid gland | 5 (71.4) | 2 (28.6) | 7.7 ± 3.7 | ||
| CNS | 3 (60.0) | 2 (40.0) | 5.2 ± 2.2 | ||
| Thyroid | 4 (100.0) | 0 | 14.8 ± 6.2 | ||
| Bowel | 3 (100.0) | 0 | 6.9 ± 3.2 | ||
| Breast | 1 (33.3) | 2 (66.7) | 2.6 | ||
| Others | 11 (100.0) | 0 | 8.9 ± 7.5 | ||
| Age, y | .055 | .295 | |||
| <70 | 83 (33.1) | 41 (66.9) | 4.6 ± 4.9 | ||
| ≥70 | 40 (18.4) | 9 (81.6) | 5.4 ± 5.0 | ||
| ECOG PS | .323 | .140 | |||
| 0-1 | 118 (70.2) | 50 (29.8) | 6.6 ± 4.5 | ||
| ≥2 | 5 (100) | 0 | 9.7 ± 4.7 | ||
| Stage | .161 | .058 | |||
| I-II | 80 (67.8) | 38 (32.2) | 4.3 ± 4.6 | ||
| III-IV | 43 (78.2) | 12 (21.8) | 5.8 ± 5.3 | ||
| LDH | .317 | .390 | |||
| Normal | 105 (69.5) | 46 (30.5) | 6.7 ± 4.4 | ||
| Elevated | 18 (81.8) | 4 (18.2) | 7.6 ± 5.1 | ||
| IPI | .000 | .578 | |||
| 0 | 28 (50.9) | 27 (49.1) | 6.1 ± 4.6 | ||
| 1 | 41 (74.5) | 14 (25.5) | 6.8 ± 4.5 | ||
| 2 | 27 (81.8) | 6 (18.2) | 6.5 ± 5.2 | ||
| ≥3 | 27 (90.0) | 3 (10.0) | 7.7 ± 3.8 | ||
| MALT-IPI | .035 | .034 | |||
| 0 | 47 (61.8) | 29 (38.2) | 3.8 ± 4.6 | ||
| 1 | 52 (75.4) | 17 (24.6) | 5.3 ± 4.6 | ||
| ≥2 | 24 (85.7) | 4 (14.3) | 6.4 ± 5.9 | ||